Prurigo nodularis forecast: Light type 2 inflammation with high chances of fibrosis.

Conrad, Curdin; Schlapbach, Christoph

Conrad, Curdin; Schlapbach, Christoph.

Affiliation

Conrad C; Department of Dermatology, CHUV University Hospital and University of Lausanne, Lausanne, Switzerland.
Schlapbach C; Department of Dermatology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address: christoph.schlapbach@insel.ch.

J Allergy Clin Immunol ; 153(1): 93-94, 2024 01.

Article in En | MEDLINE | ID: mdl-37951309

Subject(s)

Prurigo; Humans; Pruritus; Inflammation; Fibrosis

Key words

Prurigo nodularis; T(H)2 cell; atopic dermatitis; dupilumab; fibrosis; inflammation; itch; nemolizumab; pruritus; single-cell RNA sequencing; type 2 inflammation

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Prurigo Limits: Humans Language: En Journal: J Allergy Clin Immunol Year: 2024 Type: Article Affiliation country: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google